top of page

Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 - Welcome and Introduction by Dr. Claudia Henschke

  • miguel65063
  • Dec 27, 2024
  • 24 min read

Thursday, September 19, 2024 | New York Academy of Medicine (NYAM)

1216 5th Ave, New York, NY 10029



Dr. Claudia Henschke gave an introductory presentation on the first day of the 1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT, opening the conference by highlighting the long history of lung cancer screening initiatives, starting in 1992. She emphasized the significant progress made, including the recruitment of 1,000 participants by 1998 and the publication of their findings in The Lancet in 1999. The International ILCAP has now screened over 102,000 participants worldwide, with a 20-year lung cancer-specific survival rate of 80%, and 95% for early-stage detection. The conference aims to further optimize screening and treatment to improve these outcomes.



Watch Dr. Claudia Henschke's Presentation Below:

Dr. Claudia Henschke
Dr. Claudia Henschke


See Dr. Claudia Henschke's Opening Slides Below:




Expand to Read the Text Transcript







Comments


Contact Us Today

We'd love to hear from you. Please fill this form to request more information.

I'm interested in: Required
How did you hear about us? Required

Thank you for your interest.

A HeartLung representative will contact you as soon as possible!

  • Twitter
  • LinkedIn
  • Facebook
  • Instagram
  • Youtube

2450 Holcombe Blvd
TMC Innovations
Houston, TX 77021

©2025 HeartLung Corporation. All Rights Reserved. US Patent Nos US9119590*, US10695022, US11610686. and Patents Pending. AutoBMD™, AutoCAC™, AutoChamber™ and other trademarks shown on this website are protected under intellectual property rights of HeartLung Corporation in the United States.

bottom of page